Infective endocarditis: prevention and antibiotic prophylaxis.


Journal

Swiss medical weekly
ISSN: 1424-3997
Titre abrégé: Swiss Med Wkly
Pays: Switzerland
ID NLM: 100970884

Informations de publication

Date de publication:
15 02 2021
Historique:
entrez: 11 3 2021
pubmed: 12 3 2021
medline: 21 10 2021
Statut: epublish

Résumé

The Swiss societies of Infectious Diseases, Pediatric Cardiology and Cardiology and the Pediatric Infectious Disease Group of Switzerland present the current update on infective endocarditis prophylaxis in a joint initiative. The major focus of the revised recommendations is a comprehensive prevention campaign for all patients at risk for infective endocarditis. Antibiotic prophylaxis is recommended only for individuals at high risk. Within this high-risk group there is a ranking order, and the conditions are presented accordingly. Antibiotic prophylaxis is no longer recommended for patients with unrepaired ventricular septal defects and patent ductus arteriosus. Recommendations for antibiotic prophylaxis for the prevention of infective endocarditis are categorized in dental and non-dental interventions.

Identifiants

pubmed: 33705562
doi: 10.4414/smw.2021.20473
pii: Swiss Med Wkly. 2021;151:w20473
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

w20473

Auteurs

Parham Sendi (P)

3010 | SWITZERLAND.

Barbara Hasse (B)

Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.

Michelle Frank (M)

University Heart Center, Department of Cardiology, University Hospital of Zurich, Zurich, Switzerland.

Ursula Flückiger (U)

Center for Internal Medicine, Hirslanden Klinik Aarau, Aarau, Switzerland.

Katia Boggian (K)

Division of Infectious Diseases and Hospital Epidemiology, Cantonal Hospital St Gallen, St. Gallen, Switzerland.

Benoit Guery (B)

Infectious Diseases Service, Department of Medicine, University of Lausanne and Lausanne University Hospital, Lausanne, Switzerland.

Raban Jeger (R)

Department of Cardiology, University Hospital Basel and University of Basel, Basel, Switzerland.

Stephan Zbinden (S)

Cardiology Unit, Hospital Emmental, Langnau, Switzerland.

Philipp Agyeman (P)

Department of Pediatrics, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.

Walter Knirsch (W)

Pediatric Cardiology, Department of Surgery, Pediatric Heart Center, University Children's Hospital, Zurich, Switzerland.

Matthias Greutmann (M)

University Heart Center, Department of Cardiology, University Hospital of Zurich, Zurich, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH